Evidence map›Paper›PMID 34600561›Full record

ArticleRadiation oncology (London, England)2021

True abscopal effect in a patient with metastatic non-small cell lung cancer.

Oliver Vilinovszki, Nicolaus Andratschke, Martin Huellner, Alessandra Curioni-Fontecedro, Stephanie G C Kroeze

Open access · goldAbstract readCase Reports
In one paragraph

Article in Radiation oncology (London, England), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.8field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 12 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Systemic benefit of radiation therapyFrontiers in oncology · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Oliver VilinovszkiDepartment of Medical Oncology and Hematology, University Hospital Zurich, Zurich, Switzerland. oliver.vilinovszki@usz.ch.ORCID http://orcid.org/0000-0003-0866-1367
Nicolaus AndratschkeDepartment of Radiation Oncology, University Hospital Zurich, Zurich, Switzerland.
Martin HuellnerDepartment of Nuclear Medicine, University Hospital Zurich, Zurich, Switzerland.
Alessandra Curioni-FontecedroDepartment of Medical Oncology and Hematology, University Hospital Zurich, Zurich, Switzerland.
Stephanie G C KroezeDepartment of Radiation Oncology, University Hospital Zurich, Zurich, Switzerland.
University of Zurich · CHUniversity Hospital of Zurich · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSystemic response to local anticancer treatment is a phenomenon called 'abscopal effect'. The immune system is thought to play a pivotal role in its occurrence. To date, several cases have been reported, particularly in patients receiving combined local treatment and immune checkpoint inhibitors. In such cases, it is impossible to discriminate between the effects of local and systemic treatment. Only a few cases of abscopal effect have been described with radiotherapy alone. CASE PRESENTATION: Here, we report on the case of an 81-year-old woman with recurrent metastatic squamous cell carcinoma of the lung with mediastinal tumor bulk, lymph node and bone metastases. The patient refused to undergo systemic treatment, and palliative stereotactic radiotherapy of the mediastinal tumor was performed. At restaging with FDG-PET/CT, the patient presented with a decrease in size and FDG-avidity both of the irradiated site and of the lymph node and bone metastases (which did not receive radiotherapy). At 25 months after radiotherapy, the patient is still in remission at all sites.

conclusionsThis is a rare case of an abscopal effect after radiotherapy as monotherapy. It is one of the few hitherto reported for lung cancer. Several ongoing studies with a combination of radiotherapy and immunotherapy are seeking to exploit a potential synergy to induce abscopal effects.

Indexed as

Aged, 80 and overBone NeoplasmsCarcinoma, Non-Small-Cell LungFemaleHumansImmunotherapyLung NeoplasmsLymphatic MetastasisMediastinal NeoplasmsPositron Emission Tomography Computed TomographyAbscopal effectBone metastasesImmunotherapyLocalized treatmentLymph node metastasesNon-small cell lung cancerRadiotherapySystemic treatment

Identifiers

PMID34600561
PMCPMC8487536
OpenAlexW3202863753

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.